Evaluating Antibiograms To Monitor Drug Resistance

We used hospital antibiograms to assess predominant pathogens and their patterns of in vitro antimicrobial resistance in central Illinois, USA. We found a lack of information about national guidelines for in vitro antimicrobial susceptibility testing and differences in interpretation among laborator...

Descripción completa

Detalles Bibliográficos
Autores principales: El-Azizi, Mohamed, Mushtaq, Adnan, Drake, Cheryl, Lawhorn, Jerry, Barenfanger, Joan, Verhulst, Steven, Khardori, Nancy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Centers for Disease Control and Prevention 2005
Materias:
Dispatch
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3320495/
https://www.ncbi.nlm.nih.gov/pubmed/16102325
http://dx.doi.org/10.3201/eid1108.050135
_version_ 1782228843977768960
author El-Azizi, Mohamed
Mushtaq, Adnan
Drake, Cheryl
Lawhorn, Jerry
Barenfanger, Joan
Verhulst, Steven
Khardori, Nancy
author_facet El-Azizi, Mohamed
Mushtaq, Adnan
Drake, Cheryl
Lawhorn, Jerry
Barenfanger, Joan
Verhulst, Steven
Khardori, Nancy
author_sort El-Azizi, Mohamed
collection PubMed
description We used hospital antibiograms to assess predominant pathogens and their patterns of in vitro antimicrobial resistance in central Illinois, USA. We found a lack of information about national guidelines for in vitro antimicrobial susceptibility testing and differences in interpretation among laboratories in the region.
format Online
Article
Text
id pubmed-3320495
institution National Center for Biotechnology Information
language English
publishDate 2005
publisher Centers for Disease Control and Prevention
record_format MEDLINE/PubMed
spelling pubmed-33204952012-04-11 Evaluating Antibiograms To Monitor Drug Resistance El-Azizi, Mohamed Mushtaq, Adnan Drake, Cheryl Lawhorn, Jerry Barenfanger, Joan Verhulst, Steven Khardori, Nancy Emerg Infect Dis Dispatch We used hospital antibiograms to assess predominant pathogens and their patterns of in vitro antimicrobial resistance in central Illinois, USA. We found a lack of information about national guidelines for in vitro antimicrobial susceptibility testing and differences in interpretation among laboratories in the region. Centers for Disease Control and Prevention 2005-08 /pmc/articles/PMC3320495/ /pubmed/16102325 http://dx.doi.org/10.3201/eid1108.050135 Text en https://creativecommons.org/licenses/by/4.0/This is a publication of the U.S. Government. This publication is in the public domain and is therefore without copyright. All text from this work may be reprinted freely. Use of these materials should be properly cited.
spellingShingle Dispatch
El-Azizi, Mohamed
Mushtaq, Adnan
Drake, Cheryl
Lawhorn, Jerry
Barenfanger, Joan
Verhulst, Steven
Khardori, Nancy
Evaluating Antibiograms To Monitor Drug Resistance
title Evaluating Antibiograms To Monitor Drug Resistance
title_full Evaluating Antibiograms To Monitor Drug Resistance
title_fullStr Evaluating Antibiograms To Monitor Drug Resistance
title_full_unstemmed Evaluating Antibiograms To Monitor Drug Resistance
title_short Evaluating Antibiograms To Monitor Drug Resistance
title_sort evaluating antibiograms to monitor drug resistance
topic Dispatch
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3320495/
https://www.ncbi.nlm.nih.gov/pubmed/16102325
http://dx.doi.org/10.3201/eid1108.050135
work_keys_str_mv AT elazizimohamed evaluatingantibiogramstomonitordrugresistance
AT mushtaqadnan evaluatingantibiogramstomonitordrugresistance
AT drakecheryl evaluatingantibiogramstomonitordrugresistance
AT lawhornjerry evaluatingantibiogramstomonitordrugresistance
AT barenfangerjoan evaluatingantibiogramstomonitordrugresistance
AT verhulststeven evaluatingantibiogramstomonitordrugresistance
AT khardorinancy evaluatingantibiogramstomonitordrugresistance

Ejemplares similares